Mettrum Retains Independent Trading Group as Market Maker

TORONTO, ONTARIO -- (Marketwired) -- 04/20/15 -- Mettrum Health Corp. ("Mettrum" or "the Company") (TSX VENTURE: MT)(TSX VENTURE: MT.WT), a vertically integrated producer and distributer of medical cannabis products, is pleased to announce that it has retained Independent Trading Group (ITG) Inc. ("ITG") to provide market-making services, in accordance with TSX Venture Exchange ("Exchange") policies. ITG will buy and sell shares of the Company on the Exchange for the purpose of maintaining an orderly trading market for the Company's shares.

The term of the agreement is one year, beginning May 1, 2015, at a cost of $5,000 per month and allows for Mettrum to terminate the agreement on 30 days written notice. ITG will not receive shares or options as compensation. The Company and ITG are unrelated and unaffiliated entities, but ITG may have or may acquire a direct interest in the Company's shares.

About ITG

ITG specializes in market making. ITG has been providing its market making services to companies ranging from TSX Venture Exchange listed companies to certain of Canada's largest publicly traded companies for over 20 years.

ITG is a member of the Investment Industry Regulatory Organization of Canada (IIROC), Canadian Investor Protection Fund (CIPF), and is a member of all Canadian Stock Exchanges and Alternative Trading Systems.

For further information on ITG, please contact: 416-941-0046 or [email protected]

About Mettrum Health Corp.

Mettrum Health Corp. is Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., a wholly-owned subsidiary of the Company, is a Toronto-based company and a licensed producer of medical cannabis under the Marihuana for Medical Purposes Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada) (the "MMPR"), which came into effect on October 1, 2013. Mettrum received its first license from Health Canada under the MMPR on November 1, 2013 and began production of medical cannabis on the same date at its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada under the MMPR on December 11, 2014 for its other wholly-owned subsidiary, Agripharm Corp., at Agripharm's facility in Clearview, Ontario. With the Company's two licenses, Mettrum is a leading producer and vendor of medical marijuana under the MMPR system.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the results of operations. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company and Mettrum disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release.

Contacts:
Mettrum Health Corp.
Ali Mahdavi
Director, Investor Relations
416.962.3300
[email protected]

Keelan Green
Media Relations
(613) 220-2016
[email protected]

Source: Mettrum Health Corp.

You May Also Be Interested In

• ArcelorMittal S.A.: ArcelorMittal publishes its 2023 Integrated Annual Review
• LG Energy Solution to Take Firm Stance Against Patent Infringers
• Nium and Thredd Expand Partnership to Power B2B Travel Payments in APAC